We are live on ! Find out more
CA

Calton & Associates Portfolio holdings

AUM $683M
1-Year Est. Return 28.95%
This Fund
S&P 500
This Quarter Est. Return
-0.68%
1 Year Est. Return
+28.95%
3 Year Est. Return
+73.86%
5 Year Est. Return
+79.5%
10 Year Est. Return
AUM
$696M
AUM Growth
+$15M
Cap. Flow
+$26M
Cap. Flow %
3.73%
Top 10 Hldgs %
26.33%
Holding
506
New
60
Increased
129
Reduced
233
Closed
69

Sector Composition

Rank Sector Weight
1 Technology 7.39%
2 Financials 3.23%
3 Industrials 2.21%
4 Communication Services 1.73%
5 Healthcare 1.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCAT icon
426
BlackRock Capital Allocation Term Trust
BCAT
$1.68B
$156K 0.02%
11,069
+383
+4% +$5.64K
OPRA
427
Opera Ltd
OPRA
$1.8B
$145K 0.02%
10,200
-3,566
-26% -$49.3K
CHI
428
Calamos Convertible Opportunities and Income Fund
CHI
$1.06B
$131K 0.02%
12,211
-8,121
-40% -$91.1K
NMFC icon
429
New Mountain Finance
NMFC
$732M
$128K 0.02%
16,465
+2,856
+21% +$23.9K
ADAM
430
Adamas Trust
ADAM
$920M
$99.5K 0.01%
13,521
+2,400
+22% +$19.1K
MRCC
431
DELISTED
Monroe Capital Corp
MRCC
$76.1K 0.01%
+16,539
New +$95.5K
SLS icon
432
SELLAS Life Sciences
SLS
$2.19B
$46.5K 0.01%
11,000
ASPI icon
433
ASP Isotopes
ASPI
$541M
$46.4K 0.01%
+10,500
New +$62.1K
IOVA icon
434
Iovance Biotherapeutics
IOVA
$2.91B
$44.9K 0.01%
12,781
+1,575
+14% +$5.04K
IAUX
435
i-80 Gold Corp
IAUX
$1.43B
$38.8K 0.01%
25,500
+1,000
+4% +$1.71K
UIS icon
436
Unisys
UIS
$205M
$30.5K ﹤0.01%
14,750
ALLO icon
437
Allogene Therapeutics
ALLO
$732M
$27.3K ﹤0.01%
+11,170
New +$22.4K
PSQH icon
438
PSQ Holdings
PSQH
$13.5M
$23.8K ﹤0.01%
2,989
-6
-0.2% -$71
ABT icon
439
Abbott
ABT
$190B
-2,323
Closed -$291K
ADBE icon
440
Adobe
ADBE
$105B
-1,023
Closed -$358K
APP icon
441
Applovin
APP
$107B
-322
Closed -$217K
ARKW icon
442
ARK Web x.0 ETF
ARKW
$1.76B
-1,701
Closed -$251K
ATO icon
443
Atmos Energy
ATO
$28.5B
-5,262
Closed -$882K
AVK
444
Advent Convertible and Income Fund
AVK
$569M
-10,856
Closed -$136K
AZN icon
445
AstraZeneca
AZN
$247B
-1,173
Closed -$216K
BMY icon
446
Bristol-Myers Squibb
BMY
$130B
-6,716
Closed -$362K
BP icon
447
BP
BP
$111B
-6,777
Closed -$235K
CEFS icon
448
Saba Closed-End Funds ETF
CEFS
$438M
-9,562
Closed -$220K
COWG icon
449
Pacer US Large Cap Cash Cows Growth Leaders ETF
COWG
$2.29B
-21,276
Closed -$749K
CRSP icon
450
CRISPR Therapeutics
CRSP
$5.21B
-4,217
Closed -$221K

Similar funds

Calton & Associates's Q1 2026 Portfolio in Review

As of Q1 2026, Calton & Associates held 506 positions worth $696M, up 2.2% from $681M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Calton & Associates deployed $26M of net new capital in Q1 2026, opening 60 new positions and adding to 129 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 31,340 shares worth $20.4M.

By sector, the portfolio is most concentrated in Technology at 7.4% of assets, up from 6.5% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Berkshire Hathaway Class B, an estimated $2.31M trimmed.

  • Calton & Associates's largest Q1 2026 buy was State Street SPDR S&P 500 ETF Trust: 31,340 shares worth $20.4M.
  • Calton & Associates added most to Schwab Government Money Market ETF in Q1 2026, an estimated $8.39M increase.
  • Calton & Associates's biggest Q1 2026 reduction was Berkshire Hathaway Class B, cutting an estimated $2.31M.
  • Calton & Associates fully exited Marathon Petroleum in Q1 2026, selling an estimated $1.67M.
  • Calton & Associates's ten largest holdings make up 26% of its $696M portfolio in Q1 2026.
  • Calton & Associates opened 60 new positions and closed 69 in Q1 2026.
  • Calton & Associates's portfolio value rose 2.2% quarter-over-quarter to $696M.

Based on Calton & Associates's 13F filing for Q1 2026, filed 13 May 2026.